Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by JEFFS ROGER, Chief Executive Officer. Director active across 3 companies, notably Liquidia Corp. Aggregated, 46 filings have been published. Breakdown: 6 buys · 12 sells. Total volume traded: €11.7m. History available since 19 November 2021. The latest transaction was disclosed on 13 May 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
43,820 shares@ US$5.5683.9% of flowCommon StockSEC:0001104659-22-098326:0
Ideal exit: 3 Jun 2023 (T+270)
25 of 46 declarations
About JEFFS ROGER
Roger Jeffs is the Chief Executive Officer of Liquidia Corp and Axsome Therapeutics, Inc. With significant experience in the biopharmaceutical sector, he leads strategic initiatives to promote innovation and growth within these companies. His vision and leadership are essential for navigating a complex and ever-evolving environment.